Vascular endothelial growth factor and its soluble receptor in ovarian pathology

Paolo Giovanni Artini, P. G. Artini, F Cristello, Cristello F, Francesca Cristello, M Monti, Monti M, Massimiliano Monti, Cela V, V. Cela, Vito Cela, Cesare Battaglia, Battaglia C, C Battaglia, G D'Ambrogio, D'Ambrogio G, G D’Ambrogio, Genazzani AR, A. R. Genazzani, Ar Genazzani
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2005 · vol. 21(1) , pp. 50–56 · doi:10.1080/09513590500099560 · PMID:16048802 · W2091981539
Observational OA: closed CC0 ⤵ 6 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-12 ⓘ

This study measured VEGF and s-VEGFR-1 levels and their activity index in ovarian cyst fluid, finding higher VEGF in endometriosis and cancer and suggesting the activity index better reflects VEGF's role in these pathologies.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: The soluble form of the vascular endothelial growth factor (VEGF) receptor, s-VEGFR-1, may negatively regulate the action of VEGF. Our purpose was to better understand the regulation of angiogenetic processes in ovarian cysts. METHODS: Seventy-three women, 36 with serous cystoadenoma, 30 with ovarian endometriosis and seven with cystoadenocarcinoma, were enrolled. We calculated both VEGF and s-VEGFR-1 levels in cystic fluid and a VEGF activity index by means of the ratio VEGF/s-VEGFR-1. Student's t test was used for the statistical analysis. RESULTS: We found higher VEGF concentration in both endometriotic and malignant lesions than in serous cystoadenoma (p=0.03 and 0.001, respectively). Also s-VEGFR-1 concentration was higher in endometrioma than in serous cysts (p=0.005); however, there was no statistically significant difference between cystoadenoma and the malignant lesions (p=0.15). VEGF activity index in cystoadenoma, endometriotic and malignant lesions was 0.61, 0.27 and 0.50, respectively. CONCLUSIONS: VEGF certainly has an important role in both ovarian endometriosis and for cancer progression; however, the activity index may be better to investigate the real role of VEGF in the pathology we have considered.

My notes (saved in your browser only)

Condition tags

endometriosisendometrioma

MeSH descriptors

Ovarian Diseases Ovarian Neoplasms Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factor Receptor-1 Cystadenocarcinoma Cystadenocarcinoma Cystadenocarcinoma Cystadenoma, Serous Cystadenoma, Serous Cystadenoma, Serous Cyst Fluid Cyst Fluid Cyst Fluid Endometriosis Endometriosis Endometriosis Female Female Humans Humans

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (36)

Cited by (6)

Source provenance

europepmc
last seen: 2026-10-17T06:09:56.316927+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:03:18.265172+00:00
License: CC0 · commercial use OK